Company news

Shuttle Pharmaceuticals Holdings, Inc. news in 2022

Shuttle Pharmaceuticals Holdings, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Shuttle Pharmaceuticals Provides Third Quarter 2022 Corporate Update

November 14, 2022

Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study

November 2, 2022

Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors

October 31, 2022

Shuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridine

September 19, 2022

Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents for Cancer Treatment

September 14, 2022

Shuttle Pharmaceuticals Announces Closing of Initial Public Offering

September 5, 2022

Shuttle Pharmaceuticals Commences Trading on Nasdaq Under Ticker Symbol "SHPH"

August 30, 2022

Decks in 2022